| Literature DB >> 31644312 |
Kalsang Dolma1,2, Amelia E Freeman1, Gabriel Rezonzew1, Gregory A Payne3, Xin Xu3, Tamas Jilling1, J Edwin Blalock3, Amit Gaggar3, Namasivayam Ambalavanan1, Charitharth Vivek Lal1,2.
Abstract
Airway microbial dysbiosis is associated with subsequent bronchopulmonary dysplasia (BPD) development in very preterm infants. However, the relationship of airway microbiome in normal pulmonary development has not been defined. To better understand the role of the airway microbiome, we compared normal and abnormal alveolar and pulmonary vascular development in mice with or without a microbiome. We hypothesized that the lungs of germ-free (GF) mice would have an exaggerated phenotypic response to hyperoxia compared with non-germ-free (NGF) mice. With the use of a novel gnotobiotic hyperoxia chamber, GF and NGF mice were exposed to either normoxia or hyperoxia. Alveolar morphometry, pulmonary mechanics, echocardiograms, inflammatory markers, and measures of pulmonary hypertension were studied. GF and NGF mice in normoxia showed no difference, whereas GF mice in hyperoxia showed protected lung structure and mechanics and decreased markers of inflammation compared with NGF mice. We speculate that an increase in abundance of pathogenic bacteria in NGF mice may play a role in BPD pathogenesis by regulating the proinflammatory signaling and neutrophilic inflammation in lungs. Manipulation of the airway microbiome may be a potential therapeutic intervention in BPD and other lung diseases.Entities:
Keywords: bronchopulmonary dysplasia; germ free; gnotobiotic; hyperoxia; lung microbiome
Mesh:
Year: 2019 PMID: 31644312 PMCID: PMC7052667 DOI: 10.1152/ajplung.00316.2019
Source DB: PubMed Journal: Am J Physiol Lung Cell Mol Physiol ISSN: 1040-0605 Impact factor: 5.464